75 results
P
solid pancreatic lesions (SPLs)
I/C
endoscopic ultrasound (EUS) elastography combined with contrast-enhanced EUS (CE-EUS), EUS elastography, contrast-enhanced EUS (CE-EUS)
O
diagnosis of pancreatic malignancy
P
patients
I/C
EUS-PD (EUS guided pancreatic duct drainage), EUS-guided rendezvous techniques, EUS-guided PD stenting
O
technical success, clinical success, adverse events
P
high-risk individuals (HRIs)
I/C
endoscopic ultrasonography (EUS) and/or magnetic resonance imaging (MRI), EUS vs. MRI
O
detection of high-grade dysplasia or T1N0M0 adenocarcinoma
P
non-jaundiced patients with incidental DDS
I/C
EUS
O
detection of a periampullary tumour, detection of benign causal pathology
P
I/C
l, o, w, -, l, e, v, e, l, , a, r, s, e, n, i, c, , (, A, s, ), , c, o, n, c, e, n, t, r, a, t, i, o, n, , i, n, , d, r, i, n, k, i, n, g, , w, a, t, e, r, d, r, i, n, k, i, n, g, , w, a, t, e, r, , A, s, , c, o, n, c, e, n, t, r, a, t, i, o, n, s, , l, o, w, e, r, , t, h, a, n, , t, h, e, , W, H, O, , p, r, o, v, i, s, i, o, n, a, l, , g, u, i, d, e, l, i, n, e, , v, a, l, u, e, , (, 1, 0, , µ, g, /, L, )
O
p, o, o, l, e, d, , a, s, s, o, c, i, a, t, i, o, n, , b, e, t, w, e, e, n, , t, h, e, , r, e, l, a, t, i, v, e, , r, i, s, k, , o, f, , e, a, c, h, , c, a, r, d, i, o, v, a, s, c, u, l, a, r, , d, i, s, e, a, s, e, , (, C, V, D, ), , e, n, d, p, o, i, n, t, , a, n, d, , l, o, w, -, l, e, v, e, l, , A, s, , c, o, n, c, e, n, t, r, a, t, i, o, n, , i, n, , d, r, i, n, k, i, n, g, , w, a, t, e, r
P
patients with localized infections
I/C
antibiotics formulated at concentrations between 0 and 6% w/w into bone cements, gentamycin-infused bone cement mixtures
O
eradication or delay of infection onset
P
patients undergoing EUS guided enteric anastomosis
I/C
EUS-GEA using lumen-apposing metal stents (LAMS), surgery
O
technical and clinical success rates, pooled adverse events rates, study quality, publication bias, heterogeneity
P
patients with lesions within or adjacent to the digestive tract
I/C
EUS-FNB using a 22G needle, EUS-FNB using other needle sizes
O
diagnostic accuracy rate, technical success rate, adverse event rate
P
patients with intraductal papillary mucinous neoplasm (IPMN)
I/C
computed tomography (CT), magnetic resonance imaging (MRI/MRCP)/Magnetic Resonance Cholangiopancreatography (MRCP), positron emission tomography/computed tomography (PET/CT), endoscopic ultrasound (EUS), diffusion-weighted magnetic resonance imaging (DWI), diagnostic accuracy of different imaging modalities
O
sensitivity, specificity, diagnostic odds ratio (DOR), summary receiver operating characteristic curves (SROC), area under the curve (AUC)
P
PATIENTS WITH PANCREATIC CYSTIC LESIONS
I/C
EUS-GUIDED NEEDLE-BASED CONFOCAL LASER ENDOMICROSCOPY, EUS-GUIDED THROUGH-THE-NEEDLE BIOPSY, OTHER TECHNIQUES
O
DIAGNOSTIC ACCURACY FOR MUCINOUS PCLs, DIAGNOSTIC ACCURACY FOR MALIGNANT PCLs, DIAGNOSTIC SUCCESS RATE, ADVERSE EVENT RATE